Found 0 matching trials
Effect of MK0524A on Cholesterol Levels (0524A-048)
PHASE3The primary objective of the study is to assess the effects of MK0524A in r...
Location
Multiple Locations
To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)
PHASE3To evaluate the efficacy and safety of ezetimibe/simvastatin and niacin in ...
Location
Multiple Locations
Early Aortic Valve Lipoprotein(a) Lowering Trial
EARLY_PHASE1Aortic valve disease is the most common form of heart valve disease and is ...
Location
MUHC - Montreal General Hospital
Supplementation With Sirtuin Activators in Women With Increased Body Weight
NAThe goal of this clinical trial is to learn if the six-month supplementatio...
Location
Poznan University of Life Sciences
Lipid Efficacy Study (0524B-022)(COMPLETED)
PHASE3This is a 12-week clinical trial in patients with primary hypercholesterole...
Location
Multiple Locations
Effect of MK0524A on Flushing Caused by Niacin (0524A-056)
PHASE3The primary objective of the study is to assess the effects of MK0524A in r...
Location
Multiple Locations
Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients
PHASE2This open label, randomized, controlled, investigator-initiated, multi-cent...
Location
University of Health Sciences Istanbul Ümraniye Training and Research Hospital
Managing Endothelial Dysfunction in COVID-19 : A Randomized Controlled Trial at LAUMC
PHASE3COVID-19 infection was shown to cause endothelial dysfunction .
At the lev...
Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069)
PHASE3A study to assess the efficacy and tolerability of ER (Extended Release) ni...
Location
Multiple Locations
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
PHASE2This is a multi-site, double-blind, randomized clinical trial of the 5-HT2A...
Location
University of Alabama at Birmingham